MAT1A and metabolic dysfunction-associated steatotic liver disease: Conversely, the MAT1A-KO upregulates more noncanonical inflammasome regulators including caspase-4 than other models, suggesting that canonical and noncanonical inflammasome pathways are regulated differentially in various NAFLD models.